SecBot

SecBot
NYSE· Services-Medical Laboratories· CIK 0000920148

LH

LABCORP HOLDINGS INC.
$307.49 ▲ +0.95%
Prev close $304.60
Market cap$25.0B
ConsensusBuy
12-mo target$344.81 (+12.1%)
▲ Bullish
Analyst conviction 8/10
Insider Selling Cluster (3 insiders)High Impact Filing (7/10)34 New Institutional Positions16 Institutional ExitsCongressional Activity (4) Healthcare & Medical Devices
Snapshot
The big-picture read on LH right now — valuation, ownership and activity at a glance.
Market Cap
$25.0B
Cap Size
Large Cap
Analyst Consensus
Strong Buy (78%)
Inst. Holders
50 funds
Inst. Value
$16.6B
Inst. Activity
34 buys / 16 sells
Insider Activity
$0.00 buy / $8.2M sell
Insider Net $
-$8.2M
SEC Reports
15
Congressional
7 trades
Price chart 30d -7.3%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 10, 2026 SEC
Labcorp held its 2026 Investor Day, reaffirming full-year 2026 guidance and providing a long-term outlook through 2029.
8-K — Impact 5/10
Sep 10, 2026 short_volume
Short Volume: LH — 59.8% short (0.4M / 0.6M)
Short: 379,437 | Exempt: 661 | TRF Vol: 634,501 | Short Ratio: 59.8% | Off-exchange volume (dark poo
Sep 1, 2026 Insider
Oyegunwa Akinbolade was granted 750 shares
EVP, CIO & CTO
Sep 1, 2026 Insider
Vaughn Bryan T was granted 1,500 shares
EVP and President, Diagnostics
Sep 1, 2026 Insider
Meltzer Jonathan C was granted 900 shares
EVP, COO
Aug 28, 2026 SEC
Labcorp filed an 8-K announcing that management will participate in a fireside chat at the Morgan Stanley 24th Annual Gl
8-K — Impact 2/10
Aug 25, 2026 Congress
April McClain Delaney sell
$100,001 - $250,000 — House
Aug 19, 2026 SEC
President & CEO Adam H. Schechter and Director Kerrii B. Anderson executed open-market sales totaling $2.45M (0.009% of
CLUSTER — Impact 2/10
Analyst ratings buy % -1.3%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Buy 78% rate it Buy or better · 27 analysts
Strong Buy 9 33% Buy 12 44% Hold 6 22% Sell 0 0% Strong Sell 0 0%
Recent analyst actions
DateFirmActionRatingFirm rating
Sep 21, 2026Truist SecuritiesMAINTAINBuy 55%
Sep 11, 2026UBSMAINTAINBuy 55%
Sep 11, 2026BarclaysMAINTAINEqual-Weight 54%
Aug 4, 2026Piper SandlerMAINTAINNeutral 54%
Aug 3, 2026JP MorganMAINTAINOverweight 55%
Jul 31, 2026Morgan StanleyMAINTAINOverweight 55%
Jul 31, 2026Truist SecuritiesMAINTAINBuy 55%
Jul 31, 2026BarclaysMAINTAINEqual-Weight 54%
Jul 13, 2026B of A SecuritiesMAINTAINBuy 54%
Jul 13, 2026BairdMAINTAINOutperform 54%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 202691260078%
Aug 1, 202691260078%
Jul 1, 2026101350082%
Jun 1, 2026101260079%
May 1, 2026101360079%
Apr 1, 2026101360079%
Mar 1, 2026101360079%
Feb 1, 2026101360079%
Price targets
Where 16 covering analysts think LH trades over the next 12 months.
$344.81 +12.1% upside Buy
Current$307.49 Low$293.00 Median$352.50 High$385.00 16 analysts
$293.00$385.00
Analyst rating Buy· 1.7/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
15 SEC filing reports analyzed · 2 bullish, 1 bearish, 0 mixed, 12 neutral · avg impact 3.3/10.
NEUTRAL8-K5/10
Labcorp held its 2026 Investor Day, reaffirming full-year 2026 guidance and providing a long-term ou
Sep 10, 2026
NEUTRAL8-K2/10
Labcorp filed an 8-K announcing that management will participate in a fireside chat at the Morgan St
Aug 28, 2026
NEUTRALCLUSTER2/10
President & CEO Adam H. Schechter and Director Kerrii B. Anderson executed open-market sales totalin
Aug 19, 2026
NEUTRAL8-K2/10
Labcorp announced it will host an Investor Day on September 10, 2026, where management will discuss
Aug 17, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 10, 2026
short_volume
Short Volume: LH — 59.8% short (0.4M / 0.6M)
Short: 379,437 | Exempt: 661 | TRF Vol: 634,501 | Short Ratio: 59.8% | Off-exchange volume (dark pool + OTC)
Sep 7, 2026
dark_pool
Dark Pool: LH — 1.4M shares, 46,640 trades
Week starting 2026-09-07. Total ATS volume: 1,406,120 shares across 46,640 trades.
Aug 31, 2026
other
Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity
Enhanced digital experience designed to improve visibility, simplify workflows and support faster decision-making BURLINGTON, N.C., Aug. 31, 2026 /PRN
Aug 31, 2026
dark_pool
Dark Pool: LH — 0.8M shares, 41,854 trades
Week starting 2026-08-31. Total ATS volume: 842,524 shares across 41,854 trades.
Aug 24, 2026
dark_pool
Dark Pool: LH — 1.1M shares, 41,532 trades
Week starting 2026-08-24. Total ATS volume: 1,108,298 shares across 41,532 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$4.65$4.49–$4.7311.3%-0.0%10↑ 0↓$3.8B13
Next Q$4.45$4.37–$4.539.4%+0.0%10↑ 0↓$3.7B13
Current FY$18.35$18.10–$18.4811.6%+0.0%1↑ 2↓$14.7B18
Next FY$19.84$18.74–$20.438.1%+0.1%6↑ 0↓$15.5B18
Current-quarter EPS estimate — revision history
WhenEPS estimateChange vs now
Current$4.650—
7d ago$4.650—
30d ago$4.651-0.001
60d ago$4.663-0.012
90d ago$4.590+0.060
Institutional ownership
Which big funds own LH (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $16.6B total value (59,177,392 shares) as of 2026-Q2. Top holders: Erste, BlackRock,, VANGUARD. Net buying activity: 34 institutions added/increased vs 16 reduced.
Top holders — 2026-Q2
FundSharesValue% TrackedLast move
Erste Asset Management GmbH0$0.000.0%—
BlackRock, Inc.6,574,261$1.8B11.1%—
VANGUARD CAPITAL MANAGEMENT LLC5,362,254$1.5B9.1%—
VICTORY CAPITAL MANAGEMENT INC4,837,573$1.4B8.2%—
STATE STREET CORP3,907,656$1.1B6.6%—
VANGUARD PORTFOLIO MANAGEMENT LLC3,678,798$1.0B6.2%—
Boston Partners3,051,690$854.2M5.2%ADD +28.8%
Allspring Global Investments Holdings, LLC2,236,957$635.0M3.8%—
GEODE CAPITAL MANAGEMENT, LLC2,188,890$610.4M3.7%—
Select Equity Group, L.P.1,981,948$554.9M3.4%—
Recent position changes
FundActionPrevCurrentChangeValue
Boston PartnersADD2,368,7963,051,690+28.8%$854.2M
FMR LLCADD1,288,4111,904,870+47.8%$533.4M
NORGES BANKNEW—810,093—$226.8M
AmundiDOUBLED274,184596,662+117.6%$167.1M
EARNEST PARTNERS LLCADD313,073476,506+52.2%$133.4M
ALLIANCEBERNSTEIN L.P.TRIM877,428418,385-52.3%$111.6M
Squarepoint Ops LLCADD140,165258,438+84.4%$72.4M
MILLENNIUM MANAGEMENT LLCADD124,573228,043+83.1%$63.9M
Russell Investments Group, Ltd.ADD96,436141,635+46.9%$39.7M
Point72 Asset Management, L.P.TRIM259,566137,444-47.0%$38.5M
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
13 insiders, 50 transactions. Net -$8.2M — $0.00 bought, $8.2M sold.
DateInsiderTitleTypeSharesPriceValue
Sep 1, 2026Oyegunwa AkinboladeEVP, CIO & CTOAWARD750——
Sep 1, 2026Vaughn Bryan TEVP and President, DiagnosticsAWARD1,500——
Sep 1, 2026Meltzer Jonathan CEVP, COOAWARD900——
Sep 1, 2026Caveney Brian JEVP, Pres of BLS, CMO & CSOAWARD3,000——
Aug 17, 2026ANDERSON KERRII BDirectorSELL3,000$318.02$954.1K
Aug 11, 2026Schechter Adam HPresident & CEOSELL4,669$320.37$1.5M
Aug 4, 2026Summy Amy B.EVP, Chief Marketing OfficerSELL924$306.74$283.4K
Aug 3, 2026Wilkinson Peter JSVP, Chief Accounting OfficerEXERCISE1,338$209.25$280.0K
Aug 3, 2026Wilkinson Peter JSVP, Chief Accounting OfficerSELL1,338$309.23$413.8K
Aug 3, 2026Wilkinson Peter JSVP, Chief Accounting OfficerSELL82$309.22$25.4K
Congressional trades
LH trades disclosed by members of Congress, with disclosure delay.
2 members · 3 buys / 4 sells
DateMemberPartyChamberTypeAmountAssetDisclosed
Aug 25, 2026April McClain DelaneyDHOUSESELL$100,001 - $250,000Laboratory Corp of America HoldingsSep 10, 2026(17d)
Aug 7, 2026April McClain DelaneyDHOUSESELL$1,001 - $15,000Laboratory Corp of America HoldingsSep 10, 2026(35d)
Aug 6, 2026April McClain DelaneyDHOUSESELL$1,001 - $15,000Laboratory Corp of America HoldingsSep 10, 2026(36d)
Aug 5, 2026April McClain DelaneyDHOUSESELL$1,001 - $15,000Laboratory Corp of America HoldingsSep 10, 2026(37d)
Feb 19, 2026Anthony WiedRHOUSEBUY$15,001 - $50,000Laboratory Corp of America HoldingsMar 12, 2026(22d)
Feb 11, 2026April McClain DelaneyDHOUSEBUY$1,001 - $15,000Laboratory Corp of America HoldingsMar 11, 2026(29d)
Feb 4, 2026April McClain DelaneyDHOUSEBUY$1,001 - $15,000Laboratory Corp of America HoldingsMar 11, 2026(36d)
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for LH.
Shares short
2,448,617
Settlement Sep 15, 2026
Change vs prior
+16.4%
Semi-monthly cycle
Days to cover
3.3
At avg daily volume
Of shares outstanding
≈3.0%
Estimate — not % of float
All LH filing & press-release reports (15)